VERONA PHARMA PLC's ticker is VRNA and the CUSIP is 925050106. A total of 100 filers reported holding VERONA PHARMA PLC in Q3 2023. The put-call ratio across all filers is 3.08 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $733,500 | -68.5% | 45,000 | -59.1% | 0.24% | -68.6% |
| Q2 2023 | $2,325,400 | -37.9% | 110,000 | -85.3% | 0.77% | -5.4% |
| Q1 2022 | $3,743,000 | -25.7% | 750,000 | 0.0% | 0.81% | -55.0% |
| Q4 2021 | $5,040,000 | +22.6% | 750,000 | 0.0% | 1.81% | +50.2% |
| Q3 2021 | $4,110,000 | -37.2% | 750,000 | -25.0% | 1.20% | -33.1% |
| Q2 2021 | $6,540,000 | -16.7% | 1,000,000 | +6.5% | 1.80% | -2.5% |
| Q1 2021 | $7,850,000 | +38.4% | 939,043 | +15.9% | 1.84% | +46.1% |
| Q4 2020 | $5,670,000 | +12.8% | 810,000 | +0.6% | 1.26% | -13.1% |
| Q3 2020 | $5,027,000 | – | 805,556 | – | 1.45% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 4,249,918 | $69,273,663 | 7.59% |
| Aisling Capital Management LP | 1,115,352 | $18,180,238 | 7.49% |
| NEA Management Company, LLC | 5,108,563 | $91,031,474 | 7.03% |
| Octagon Capital Advisors LP | 2,369,000 | $38,614,700 | 5.93% |
| Knoll Capital Management, LLC | 200,000 | $3,260,000 | 3.38% |
| Frazier Life Sciences Management, L.P. | 3,014,349 | $49,133,889 | 3.26% |
| Perceptive Advisors | 4,007,197 | $65,317,311 | 2.18% |
| RA Capital Management | 6,317,990 | $102,983,237 | 2.03% |
| Deep Track Capital, LP | 3,187,415 | $51,954,865 | 2.00% |
| Carlyle Group Inc. | 2,457,500 | $40,008,100 | 1.74% |